BeOne Medicines Ltd.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

FY: Dec 31 2024

FY: Dec 31 2023

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Other Events

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Other Events

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Termination of a Material Definitive Agreement

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Unregistered Sales of Equity Securities

Results of Operations and Financial Condition

Other Events

Results of Operations and Financial Condition

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Automatic Shelf Registration

Automatic Shelf Registration

Notice of Effectiveness

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post-effective amendment to a registration statement

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Notice of Effectiveness

Registration statement under the Securities Act of 1933 for depositary shares evidenced by American depositary receipts (amendment)

Registration statement under the Securities Act of 1933 for depositary shares evidenced by American depositary receipts

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933 (amendment)

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

No description available

Definitive Proxy Statement

Preliminary Proxy Statement

Lee Chan Henry

Wang Xiaodong

Lee Chan Henry

BAKER JULIAN; BAKER FELIX; BAKER BROS. ADVISORS LP; Baker Brothers Life Sciences LP; 667, L.P.; Baker Bros. Advisors (GP) LLC

BAKER BROS. ADVISORS LP

Wang Xiaodong

Wang Xiaodong

Ball Titus B.

Ball Titus B.

Wu Xiaobin

Sanders Corazon (Corsee) D.

Wu Xiaobin

Lee Chan Henry

OYLER JOHN

Lee Chan Henry

OYLER JOHN

Rosenberg Aaron

Rosenberg Aaron

Lee Chan Henry

Lee Chan Henry

Annual Report Scanned (Paper)

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Post-effective amendment to an automatic shelf registration statement

Post-effective amendment to an automatic shelf registration statement

Entry into a Material Definitive Agreement

Annual Report Scanned (Paper)

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Annual Report Scanned (Paper)